Ignite Creation Date:
2025-12-24 @ 4:52 PM
Ignite Modification Date:
2025-12-29 @ 9:51 PM
Study NCT ID:
NCT05123950
Status:
COMPLETED
Last Update Posted:
2021-11-17
First Post:
2021-10-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-19
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-19
First Submit QC Date:
None
Study First Post Date:
2021-11-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-15
Last Update Post Date:
2021-11-17
Last Update Post Date Type:
ACTUAL